Presentations

MONDAY, 13 NOVEMBER 2023
Opening Session

Welcome to the HepHIV 2023 Madrid Conference
Daniel Simões, HepHIV2023 Conference Co-chair, Coalition Plus/GAT, Portugal
Video

Welcome to Madrid
Opportunities to achieve zero stigma and discrimination in integrated HIV, STIs and Viral Hepatitis responses: the perspective of the Ministry of Health
Julia del Amo, Director of the HIV, STIs, viral hepatitis and tuberculosis Control Division, Ministry of Health, Spain Local conference co-chair
Video

Opportunities to achieve zero stigma and discrimination in integrated HIV, STIs and Viral Hepatitis responses: the clinical perspective 
Arkaitz Imaz, MD, PhD, Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and Bellvitge University Hospital, Barcelona, Spain, Local co- chair 
Video

Opportunities to achieve zero stigma and discrimination in integrated HIV, STIs and Viral Hepatitis responses: the community perspective 
Alejandro Bertó Moran, Professor, Coordinator of ADAHARA and founder Seville Check Point
Video

The perspective of the Scientific Societies
José Perez Molina, President of Sociedad Española Interdisciplinar del SIDA (SEISIDA)
Video

The perspective of the Scientific Societies    
Arkaitz Imaz, MD, PhD, Board member of Gesida (Study Group on HIV of the Spanish Society of Infectious Diseases and Clinical Microbiology)
Video

Keynote from the European Commission    
Stefan Schreck, Adviser for Stakeholder Relations, Directorate-General for Health and Food Safety (DG SANTE)
Video

Welcome message from the Minister of Health of Spain     
José Manuel Miñones, Minister of Health of Spain
Video

Setting the scene: What is needed to reach the Sustainable Development Goals in terms of testing and linkage to care?
Andrea Ammon, Director, European Centre for Disease Prevention and Control (ECDC) (by video)
Video

Keynote from WHO: Resetting the course towards ending AIDS and eliminating the epidemic of viral hepatitis  
Hans Kluge, Regional Director, WHO Regional Office for Europe (by video)
Video

TUESDAY, 14 NOVEMBER 2023

PLENARY SESSION 1: How to overcome stigma and discrimination in accessing testing services for HIV, viral hepatitis, TB and STIs

Overview of research – Stigma as a barrier for testing (HIV, viral hepatitis, TB and STIs)    
Maria José Fuster, Director of the Spanish AIDS Society (SEISIDA)
Video

ECDC survey on measuring stigma among people living with HIV in Europe in health care and community settings    
Teymur Noori, European Centre for Disease Prevention and Control (ECDC)
Video

Lived experience with stigma     
Harun Tulunay, Training and Volunteer Coordinator, Positively UK
Video 

Stigma Index 2.0: People living with HIV stigma index, in Portugal    
Ana Duarte, Head of Prevention and Training Department, Ser+ - Portuguese Association for AIDS Challenge and Prevention
Video

Discussion 

PLENARY SESSION 2: Integrated testing and integrated services – what is the status?

Keynote presentation: Ending HIV Transmission in England in a ‘post-pandemic’ world: What is possible?
Kevin Fenton, Regional Director of Public Health, NHS London. Chief Advisor on HIV to Government
Video

Integrating testing for HIV/STI/VH and TB - when and where? - challenges and opportunities
Viatcheslav Grankov, WHO Regional Office for Europe
Video

Good practices of integrated POC testing for HCV, HIV other STIs and TB with harm reduction strategies for PUD
Elisa Martró, Institut de Recerca Germans Trias i Pujol (IGTP)
Video

Integrated HIV, viral hepatitis and syphilis testing: findings from the Portuguese Community Screening Network
Paula Meireles, Institute of Public Health of the University of Porto (EPIUnit-ISPUP)

Discussion

PARALLEL ABSTRACT DRIVEN SESSION 1: Improving BBV Testing Strategies in Emergency Departments

Impact of Hepatitis C Virus (HCV) Screening in an Emergency Department: implementation of the FOCUS program in Almería, Spain 
A Camelo Castillo, University Hospital Torrecárdenas, Spain
Video

Integrating Viral Hepatitis Screening into the Emergency Department: evaluating middle-term results and implications for sustaining a screening 
J Carlos Ruiz Cobo, Vall d'Hebron University Hospital, Spain
Video

Opt out Blood Borne Virus (BBV) testing in 33 Emergency Departments (EDs) in areas of high and extremely high HIV prevalence in England
R Hill-Tout, NHS England, United Kingdom

Outcomes from Partner Notification in the ED HIV Testing Programme 
A Cartier, Chelsea and Westminster Hospital NHS Trust, United Kingdom
Video

Evaluating opt-out testing for HIV, hepatitis B and hepatitis C at 5 emergency departments in London, UK
R Roche, UK Health Security Agency, United Kingdom
Video

Discussion

PARALLEL ABSTRACT DRIVEN SESSION 2: Combination Prevention: Optimizing Implementation of Testing and PrEP

Incidence and factors associated with PrEP discontinuation 
N Garofoli, Bichat-Claude Bernard Hospital, France
Video

Perceived impact of digital health instruments on PrEP uptake in the UK: a discrete choice experiment with 810 gay, bisexual and queer men
I Kuchin, Management Center Innsbruck, Austria
Video

A Community-Based Organization's Role in HIV PrEP Referral and Monitoring: An Examination of Practices and Challenges 
M Rocha, Grupo de Ativistas em Tratamentos (GAT), Portugal
Video

Chemsex, HIV testing and associated factors in gay, bisexual and other men who have sex with men and transgender people, among European community-based centres
M Alarcon Gutierrez, Centre of Epidemiological Studies of HIV/AIDS and STI of Catalonia (CEEISCAT), Health Department, Generalitat de Catalunya, Spain
Video

Building a HIV combination prevention and testing services checklist to assess their availability, quality and access by key populations
A I von Lingen, European AIDS Treatment Group, Belgium
Video

STI incidence and PrEP uptake in participants from underserved populations in the HIV Pre-exposure Prophylaxis (PrEP) Impact trial
D Ogaz, UK Health Security Agency (UKHSA)/Chelsea and Westminster Hospital NHS Trust, United Kingdom
Video

Discussion

PLENARY SESSION 3 / SPECIAL SESSION: Migrants and mobile populations – testing and linkage to care

Overview of different testing services for blood born viruses and linkage to care among different migrant population groups across Europe    
Denis Onyango, Director of Programmes at Africa Advocacy Foundation
Video 

Engaging and linking to care displaced and mobile populations - Challenges and experiences from the Ukrainian crisis    
Milosz Parczewski, Professor, Pomeranian Medical University
Video

HIV positive diagnosis among migrants compared to native-born in Europe and Central Asia: COBATEST network, 2021-2022    
Megi Gogishvili, Coordinator of COBATEST, Centre of Epidemiological Studies of HIV/AIDS and STI of Catalonia (CEEISCAT)
Video

Panel Discussion
Denis Onyango, Director of Programmes at Africa Advocacy Foundation
Deniz Gökengin, Professor, Director of Ege University HIV/AIDS Practice and Research Center 
Jose A. Perez Molina, SEISIDA
Megi Gogishvili, Coordinator of COBATEST, Centre of Epidemiological Studies of HIV/AIDS and STI of Catalonia (CEEISCAT)
Milosz Parczewski, Professor, Pomeranian Medical University
Valeriia Rachynska, 100% Life

WEDNESDAY, 15 NOVEMBER 2023 

PLENARY SESSION 4: Self-testing and self-sampling to increase testing coverage 

Short report from Day 1    
Jürgen Rockstroh, HepHIV2023Conference Co-chair, HIV Outpatient Clinic, University of Bonn, Germany
Video

Overview of self-testing/self-sampling devices and diagnostic technologies for HIV, STIs and viral Hepatitis     
Irith De Baetselier, Antwerp Institute of Tropical Medicine, Belgium
Video

Challenges and barriers for implementation of a self-testing and self-sampling approach: regulatory barriers, practical challenges, linkage to care and data protection in the European Region    
John de Wit, Professor,Utrecht University
Video 

High acceptability and effectiveness of an online self-sampling intervention for HIV, hepatitis C virus and bacterial STIs addressed to gay, bisexual and other men who have sex with men and trans women in Spain (TESTATE)    
Cristina Agusti, CEEISCAT-Agència de Salut Pública de Catalunya
Video

Discussion

PARALLEL ABSTRACT DRIVEN SESSION 3: HCV Screening Among Key Populations

Risk factors for sexual HCV transmission in men-who-have-sex-with-men and behavioural trajectories 2019–21. Results from a case-control analysis nested within a multi-centre cohort study in Germany 
A Jeremias Schmidt, London School of Hygiene and Tropical Medicine, United Kingdom

Making hepatitis C screening and treatment more accessible for people who use drugs and homeless people: A test and treat Mobile Unit in Catalonia
M Portela, Red Cross, Spain
Video

Hepatitis B and C screening and linkage to care in migrants from endemic countries in Barcelona through the implementation of the HepBClink community action
A Not Gari, Microbiology Department, Laboratori Clínic Metropolitana Nord (LCMN), Hospital Universitari Germans Trias i Pujol. Germans Trias i Pujol Research Institute (IGTP), Badalona (Barcelona), Spain
Video

A low rate of individuals are screened for hepatitis C in primary care centers in Barcelona
E Vargas Accarino, Vall d'Hebron Universitary Hospital, Spain
Video

Increasing testing for HIV and hepatitis through European Testing Week – lessons learned from 10 years of a regional awareness campaign
B Collins, European Testing Week, United Kingdom
Video

Discussion

PARALLEL ABSTRACT DRIVEN SESSION 4:Self-testing Strategies and Factors Affecting Testing Patterns

Impact of the SARS-CoV-2 epidemic and wartime migration on the number of clients at testing sites in Poland
A Szczepański, Foundation for Social Education, Poland
Video

Piloting HIV self-testing strategies for sexual partners of MSM, female and transgender sex workers
N Tsereteli, Center for Information and Counseling on Reproductive Health – Tanadgoma, Georgia
Video

More than 95% return rate in a community-based HIV self-testing project in the Netherlands
O Shobowale, AIDS Healthcare Foundation, The Netherlands
(Pre-recording)
Video

Self-sampling with oral rinse to detect oropharyngeal Neisseria gonorrhoeae among men who have sex with men (SSONG study): preliminary results
T Vanbaelen, Institute of Tropical Medicine, Belgium
Video

Initial outcomes from 6150 orders from a national hepatitis C self-sampling service: a commissioned strategy to increasing Hepatitis C testing and treatment
M Gillyon-Powell, NHS England, United Kingdom
Video

Discussion

PLENARY SESSION 5 Emerging, intersecting and competing epidemics – challenges in responding to testing and linkage to care 

Case Study: Mpox as a Community-Driven Syndemic Response
Demetre Daskalakis, Acting Director for the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Disease Control and Prevention (CDC) (by video) 

Reliable diagnostic ability during an infectious emergency    
Jens Lundgren, Professor, Director of CHIP, Rigshospitalet, University of Copenhagen

Panel Discussion     
Demetre Daskalakis, Acting Director for the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Disease Control and Prevention (CDC) (online participation)
Jens Lundgren, Professor, Director of CHIP, Rigshospitalet, University of Copenhagen
Luis Mendão, Director of Advocacy, Health Policies at Grupo de Ativistas em Tratamento (GAT) 
Magdalena Ankiersztejn-Bartczak, European AIDS Treatment Group (EATG)
Ricardo Fuertes, Advisor to the Secretary of State of Health Promotion, Portugal 
Stefan Schreck, Adviser for Stakeholder Relations, Directorate-General for Health and Food Safety (DG SANTE)
Stela Bivol, Unit lead at WHO Regional Office for Europe 

CLOSING SESSION 
Short report from Conference Day 2 and Best Poster Award    
Jürgen Rockstroh, HepHIV2023 Conference Co-chair, HIV Outpatient Clinic, University of Bonn, Germany
Video

Challenges and opportunities for tackling infectious diseases in the Eastern European Region – current status and prospects for the years ahead    
Michel Kazatchkine, Senior advisor to WHO Europe
Video

How do we keep testing and linkage to care for HIV and co-infections on the political agendas at national and European level    
Ricardo Baptista Leite, President and Founder of UNITE Parliamentarians Network for Global Health
Video

Feedback from the high-level HIV meeting Spanish Presidency of the European Union  Julia del Amo, Director of the HIV, STIs, viral hepatitis and tuberculosis Control Division, Ministry of Health, Spain Local conference co-chair.
Video

Conference Call to Action and closing remarks        
Daniel Simões, HepHIV2023 Conference Co-chair, Coalition Plus/GAT, Portugal 
Video

POSTER PRESENTATIONS

Poster Category 1: Improving BBV Testing Strategies in Emergency Departments
PO1/01    Reassessing HIV Detection Strategies: An Analysis of Opportunistic Screening vs. Indicator-Condition-Driven Diagnosis in Valencia, Spain

PO1/02    Blood-Borne Virus testing in European Emergency Departments: Current Evidence and Service Considerations

PO1/03    Screening and Diagnosis of Hepatitis C Virus in Emergency Departments

PO1/04    Leveraging Emergency Department Visits for Hepatitis C Virus (HCV) Screening 

PO1/05    Targeted screening for HIV infection in emergency departments. Two-year experience in 20 Catalan hospitals. VIHGILA Project 

PO1/06    Hepatitis C virus screening strategies implemented in an emergency department and first results 

Poster Category 2: Combination Prevention: Optimizing Implementation of Testing and PrEP
PO2/01    “'Don't Hurt Me, No More'. Unveiling Violence in Online Transactional Sex: A Study on Men (cis and trans), Trans Women, and Non-Binary People in France 
BEST POSTER AWARD

PO2/02    Community Based Organizations' Best Practices for HIV Comprehensive Prevention Services 

PO2/03    Identifying healthcare needs in users of community level screening centers for STIs in Madrid and Torremolinos in 2022

PO2/04    Choices@AZC: Prevention Services in Asylum Seekers Centers

PO2/05    Delivering “U=U” Standardized Messages to PLWHA Accessing Services at the Baylor Clinical Center of Excellence in Constanta, Romania

PO2/06    Key learning on integrating chemsex services 

PO2/07    Can We Increase Perceived Vulnerability to Becoming HIV/HEP Infected Among Students in the General Population to Get Them Thinking about Testing? 

PO2/08    Awareness and use of pre-exposure prophylaxis for HIV infection among people who inject drugs and tested negative in six cities of Tajikistan, 2022 

Poster Category 3: HCV Screening among Key Populations
PO3/02    Pilot study of a simplified HCV management algorithm in Opioid Agonist Treatment clinics in Ukraine

PO3/03    Prospective evaluation of an outsourced consultation model specialized with educational intervention to reduce reinfection by the hepatitis C virus in a harm reduction center

PO3/04    Current status of hepatitis delta in Andalusia: Multicenter study

PO3/06    On the road to HCV elimination: one step closer to WHO goal with linkage-to-care services in Croatian penalty institutions by Hepatos’s mobile clinic named Mobile InfoHep Centre (MIHC) 

PO3/07    Prevention, Diagnosis, Treatment and Monitoring of Hepatitis C (Liga Portuguesa Contra a SIDA) 

PO3/08    A fast-track HIV and viral hepatitis screening service in Barcelona, Spain

Poster Category 4: Self-testing Strategies and Factors Affecting Testing Patterns   
PO4/01    A self-sampling screening strategy addressed to asymptomatic or unrecognized monkeypox virus infection in gay, bisexual, and other men who have sex with men and trans women in Spain

PO4/02    Assessment of HIV self-testing and self-sampling use and intention to use among COBATEST Network members

PO4/03    Results of HIV – Self Testing Pilot Program in an Environment with Structural Challenges: Youth in the General Population Show Satisfaction with the Physical Characteristics of Tests

Poster Category 5: Epidemiology, Vaccination and Healthcare
PO5/01    HIV Epidemiology among Ukrainian Individuals Migrating to Denmark in 2022

PO5/02    HIV criminalisation in the EU: a comparative 20-country report

PO5/03    HIV/HCV PROJECT: AWARENESS, EARLIER AND EASIER DIAGNOSIS OF HIV AND HCV INFECTIONS IN THE METROPOLITAN CITY OF TURIN

PO5/04    Knowledge, attitude and practices about hepatitis B vaccination among people who inject drugs in Georgia

PO5/05    Are men who have sex with men (MSM) living in Portugal being systematically vaccinated for hepatitis virus?

PO5/06    Digitally targeted testing for blood borne viruses: Systematic review and algorithm development (TARGET-ID)

PO5/07    Results of implementation of integrated rapid testing for HIV, hepatitis B and C and Syphilis on the base of healthcare facilities and community level in Ukraine 

Poster Category 6: Community Leadership in Responding to Infectious Disease Threats
PO6/01     Legal and Policy Barriers to the Provision of Community-based HIV testing services in Europe and Central Asia

PO6/02    CORE - Community Response to End Inequalities

PO6/03    Point of care screening activity for HIV and other STIs at a community center in Madrid and Torremolinos – 2022

PO6/04     Tailor-made community based services may be effective in reaching the most vulnerable MSM and transgender migrants with HIV and STI testing: Preliminary results of the Project Crossing Countries, Crossing Communities in three European countries

PO6/06    The contribution of Liga Portuguesa Contra a SIDA (LPCS) to diagnosis and treatment of Tuberculosis in Lisboa, Loures and Odivelas 

PO6/07    Spanish network for HIV testing in the community level (RedCoVIH). Data from 2022 

PO6/08    Where do women get tested more often for HIV, HCV and syphilis in Warsaw at the stationary checkpoints or at the socio-cultural event?